{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:58:35Z","timestamp":1788872315761,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Research Fund for the Control of Infectious Diseases","award":["09080812"],"award-info":[{"award-number":["09080812"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.vaccine.2010.08.049","type":"journal-article","created":{"date-parts":[[2010,8,22]],"date-time":"2010-08-22T04:38:18Z","timestamp":1282451898000},"page":"7233-7240","source":"Crossref","is-referenced-by-count":30,"title":["Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant"],"prefix":"10.1016","volume":"28","author":[{"given":"Guangyu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanying","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Lustigman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Jian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5349","key":"10.1016\/j.vaccine.2010.08.049_bib0005","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1126\/science.279.5349.393","article-title":"Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness","volume":"279","author":"Subbarao","year":"1998","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2010.08.049_bib0010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.20506\/rst.28.1.1868","article-title":"Molecular epidemiology of H5N1 avian influenza","volume":"28","author":"Guan","year":"2009","journal-title":"Rev Sci Technol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.08.049_bib0015","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3201\/eid1303.061125","article-title":"Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1","volume":"13","author":"Tompkins","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"23\u201324","key":"10.1016\/j.vaccine.2010.08.049_bib0020","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1016\/j.vaccine.2004.02.021","article-title":"Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys","volume":"22","author":"Fan","year":"2004","journal-title":"Vaccine"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2010.08.049_bib0025","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/S0264-410X(03)00040-9","article-title":"Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2","volume":"21","author":"Mozdzanowska","year":"2003","journal-title":"Vaccine"},{"issue":"44\u201346","key":"10.1016\/j.vaccine.2010.08.049_bib0030","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1016\/j.vaccine.2006.05.082","article-title":"Improved design and intranasal delivery of an M2e-based human influenza A vaccine","volume":"24","author":"De Filette","year":"2006","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2010.08.049_bib0035","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s10529-009-0102-6","article-title":"Increasing M2 epitope density enhances systemic and mucosal immune responses to influenza A virus","volume":"31","author":"Pei","year":"2009","journal-title":"Biotechnol Lett"},{"issue":"10","key":"10.1016\/j.vaccine.2010.08.049_bib0040","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat Med"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2010.08.049_bib0045","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1016\/j.vaccine.2008.04.052","article-title":"Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform","volume":"26","author":"Denis","year":"2008","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2010.08.049_bib0050","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1007\/s11033-009-9846-2","article-title":"Heterologous expression, purification and characterization of the influenza A virus M2e gene fused to Mycobacterium tuberculosis HSP70 (359\u2013610) in prokaryotic system as a fusion protein","volume":"37","author":"Ebrahimi","year":"2010","journal-title":"Mol Biol Rep"},{"issue":"7","key":"10.1016\/j.vaccine.2010.08.049_bib0055","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s11259-009-9222-7","article-title":"Enhancement of mucosal immune response against the M2eHBc+ antigen in mice with the fusion expression products of LTB and M2eHBc+ through mucosal immunization route","volume":"33","author":"Zhang","year":"2009","journal-title":"Vet Res Commun"},{"issue":"2","key":"10.1016\/j.vaccine.2010.08.049_bib0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.vaccine.2007.10.062","article-title":"Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin","volume":"26","author":"Huleatt","year":"2008","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2010.08.049_bib0065","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.vaccine.2007.12.027","article-title":"CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine","volume":"26","author":"Eliasson","year":"2008","journal-title":"Vaccine"},{"issue":"26","key":"10.1016\/j.vaccine.2010.08.049_bib0070","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1016\/j.vaccine.2005.01.098","article-title":"rOv-ASP-1, a recombinant secreted protein of the helminth Onchocerca volvulus, is a potent adjuvant for inducing antibodies to ovalbumin, HIV-1 polypeptide and SARS-CoV peptide antigens","volume":"23","author":"MacDonald","year":"2005","journal-title":"Vaccine"},{"issue":"39","key":"10.1016\/j.vaccine.2010.08.049_bib0075","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1016\/j.vaccine.2008.07.028","article-title":"Evaluation of recombinant Onchocerca volvulus activation associated protein-1 (ASP-1) as a potent Th1-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactivated vaccines","volume":"26","author":"Xiao","year":"2008","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2010.08.049_bib0080","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.4049\/jimmunol.0800531","article-title":"Recombinant Ov-ASP-1, a Th1-biased protein adjuvant derived from the helminth Onchocerca volvulus, can directly bind and activate antigen-presenting cells","volume":"182","author":"He","year":"2009","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2010.08.049_bib0085","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","article-title":"Jalview Version 2 \u2013 a multiple sequence alignment editor and analysis workbench","volume":"25","author":"Waterhouse","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2010.08.049_bib0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1743-422X-7-9","article-title":"An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses","volume":"7","author":"Zhao","year":"2010","journal-title":"Virol J"},{"issue":"2","key":"10.1016\/j.vaccine.2010.08.049_bib0095","doi-asserted-by":"crossref","first-page":"948","DOI":"10.4049\/jimmunol.180.2.948","volume":"180","author":"Du","year":"2008","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.08.049_bib0100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11262-008-0305-2","article-title":"Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus","volume":"38","author":"Chen","year":"2009","journal-title":"Virus Genes"},{"issue":"23","key":"10.1016\/j.vaccine.2010.08.049_bib0105","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1016\/j.vaccine.2009.03.023","article-title":"Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses","volume":"27","author":"Patel","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2010.08.049_bib0110","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.vaccine.2004.05.028","article-title":"High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity","volume":"23","author":"Liu","year":"2004","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2010.08.049_bib0115","doi-asserted-by":"crossref","first-page":"11382","DOI":"10.1074\/jbc.M800650200","article-title":"An influenza A vaccine based on tetrameric ectodomain of matrix protein 2","volume":"283","author":"De Filette","year":"2008","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.vaccine.2010.08.049_bib0120","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/JVI.62.8.2762-2772.1988","article-title":"Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions","volume":"62","author":"Zebedee","year":"1988","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2010.08.049_bib0125","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.4049\/jimmunol.172.9.5598","article-title":"Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity","volume":"172","author":"Jegerlehner","year":"2004","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.08.049_bib0130","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1006\/viro.1998.9534","article-title":"Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection","volume":"254","author":"Mozdzanowska","year":"1999","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2010.08.049_bib0135","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.antiviral.2008.06.002","article-title":"Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein","volume":"80","author":"Wang","year":"2008","journal-title":"Antiviral Res"},{"issue":"32","key":"10.1016\/j.vaccine.2010.08.049_bib0140","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1016\/j.vaccine.2009.04.075","article-title":"The co-administration of CpG-ODN influenced protective activity of influenza M2e vaccine","volume":"27","author":"Wu","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2010.08.049_bib0145","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1371\/journal.ppat.0030040","article-title":"H5N1 viruses and vaccines","volume":"3","author":"Subbarao","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2010.08.049_bib0150","first-page":"431","article-title":"Vaccines for pandemic influenza: summary of recent clinical trials","volume":"333","author":"Keitel","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"issue":"43","key":"10.1016\/j.vaccine.2010.08.049_bib0155","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.1016\/j.vaccine.2008.11.037","article-title":"Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine","volume":"27","author":"Wu","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2010.08.049_bib0160","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.09.6","article-title":"Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments","volume":"8","author":"Schotsaert","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"9348","key":"10.1016\/j.vaccine.2010.08.049_bib0165","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(02)11772-7","article-title":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?","volume":"360","author":"Cheung","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.08.049_bib0170","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1465-9921-6-135","article-title":"Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells","volume":"6","author":"Chan","year":"2005","journal-title":"Respir Res"},{"issue":"23","key":"10.1016\/j.vaccine.2010.08.049_bib0175","doi-asserted-by":"crossref","first-page":"8091","DOI":"10.1073\/pnas.0711942105","article-title":"Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A\/H5N1 virus","volume":"105","author":"Zheng","year":"2008","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10011941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10011941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T16:34:21Z","timestamp":1591806861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10011941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":35,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0264410X10011941"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.08.049","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}